Asan Medical Center Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery.
Two-Year Follow-up from a Prospective, Randomized Trial of Heparin Plus Glycoprotein IIb/IIIa Inhibitors vs. Bivalirudin and Paclitaxel-Eluting vs. Bare-Metal.
Oxford The John Radcliffe Hospital Multi-vessel disease… Le Mans implications Dr Adrian Banning.
Drug Eluting Stents (DES)
Nice Guidelines for 18/52 wait and the Patient Pathway ...
AHA 2010 research highlights: A slideshow presentation
boston scientific2004_annual_financial
The TAXUS™ Paclitaxel-Eluting Stent Program. The safety and effectiveness of the TAXUS ™ Express 2 ™ Stent has not been established in patients with coronary.
Journal Club: Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease Tiffany Sun, MD May 19, 2009.
Coronary Stenting: Drug-eluting vs Bare-metal Natalie Cleaver, PA-S Lock Haven University PA Program Evidence Based Medicine February 26, 2009.
Seung-Jung Park, MD, PhD and Ki-Bae Seung, MD, PhD, on behalf of the MAIN-COMPARE Study Group
Unrestricted Use of Drug-Eluting Stents Compared with Bare-Metal Stents in Routine Clinical Practice: Findings From the National Heart, Lung, and Blood.
